The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Diversion of aspartate in ASS1-deficient tumours fosters de novo pyrimidine synthesis
Open accessAbstract
Cancer cells hijack and remodel existing metabolic pathways for their benefit. Argininosuccinate synthase (ASS1) is a urea cycle enzyme that is essential in the conversion of nitrogen from ammonia and aspartate to urea. A decrease in nitrogen flux through ASS1 in the liver causes the urea cycle disorder citrullinaemia. In contrast to the well-studied consequences of loss of ASS1 activity on ureagenesis, the purpose of its somatic silencing in multiple cancers is largely unknown. Here we show that decreased activity of ASS1 in cancers supports proliferation by facilitating pyrimidine synthesis via CAD (carbamoyl-phosphate synthase 2, aspartate transcarbamylase, and dihydroorotase complex) activation. Our studies were initiated by delineating the consequences of loss of ASS1 activity in humans with two types of citrullinaemia. We find that in citrullinaemia type I (CTLN I), which is caused by deficiency of ASS1, there is increased pyrimidine synthesis and proliferation compared with citrullinaemia type II (CTLN II), in which there is decreased substrate availability for ASS1 caused by deficiency of the aspartate transporter citrin. Building on these results, we demonstrate that ASS1 deficiency in cancer increases cytosolic aspartate levels, which increases CAD activation by upregulating its substrate availability and by increasing its phosphorylation by S6K1 through the mammalian target of rapamycin (mTOR) pathway. Decreasing CAD activity by blocking citrin, the mTOR signalling, or pyrimidine synthesis decreases proliferation and thus may serve as a therapeutic strategy in multiple cancers where ASS1 is downregulated. Our results demonstrate that ASS1 downregulation is a novel mechanism supporting cancerous proliferation, and they provide a metabolic link between the urea cycle enzymes and pyrimidine synthesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Genetic or epigenetic silencing of ASS1 expression provides an advantage to tumor cells by allowing them to preserve cellular aspartate (Rabinovich et al., 2015), a poorly transported nutrient that can be a critical output of the TCA cycle to support de novo nucleotide synthesis and cell proliferation (Birsoy et al., 2015; Sullivan et al., 2015).”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Rabinovich et al., 2015
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global reconstruction of the human metabolic network based on genomic and bibliomic data
Duarte, N. C., Becker, S. A., Jamshidi, N., Thiele, I., Mo, M. L., Vo, T. D., Srivas, R., & Palsson, B. Ø. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610772104 · Cited by 1,374
Metabolic Flux Balancing: Basic Concepts, Scientific and Practical Use
Varma, A., & Palsson, B. Ø. (1994) · Nature Biotechnology · doi:10.1038/nbt1094-994 · Cited by 945
Stimulation of de novo pyrimidine synthesis by growth signaling through mTOR and S6K1
Ben-Sahra, I., Howell, J. J., Asara, J. M., & Manning, B. D. (2013) · Science · doi:10.1126/science.1228792 · Cited by 739
Quantitative Phosphoproteomics Reveal mTORC1 Activates de Novo Pyrimidine Synthesis
Robitaille, A. M., Christen, S., Shimobayashi, M., Cornu, M., Fava, L. L., Moes, S., Prescianotto-Baschong, C., Sauer, U., Jenoe, P., & Hall, M. N. (2013) · Science · doi:10.1126/science.1228771 · Cited by 525
Recent advances in arginine metabolism: roles and regulation of the arginases
Morris Jr, S. M. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00278.x · Cited by 485
Predicting selective drug targets in cancer through metabolic networks
Folger, O., Jerby‐Arnon, L., Frezza, C., Gottlieb, E., Ruppin, E., & Shlomi, T. (2011) · Molecular Systems Biology · doi:10.1038/msb.2011.35 · Cited by 480
Self-citationArginine deprivation and argininosuccinate synthetase expression in the treatment of cancer
Delage, B., Fennell, D. A., Nicholson, L., McNeish, I., Lemoine, N. R., Crook, T., & Szlosarek, P. W. (2010) · International Journal of Cancer · doi:10.1002/ijc.25202 · Cited by 441
Single-molecule transcript counting of stem-cell markers in the mouse intestine
Itzkovitz, S., Lyubimova, A., Blat, I. C., Maynard, M. A., van Es, J. H., Lees, J. A., Jacks, T., Clevers, H. C., & van Oudenaarden, A. (2011) · Nature Cell Biology · doi:10.1038/ncb2384 · Cited by 352
Self-citationLee, J. K., Havaleshko, D. M., Cho, H., Weinstein, J. N., Kaldjian, E. P., Karpovich, J. F., Grimshaw, A. S., & Theodorescu, D. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610292104 · Cited by 311
Integrative Genome Comparison of Primary and Metastatic Melanomas
Kabbarah, O., Nogueira, C., Feng, B., Nazarian, R. M., Bosenberg, M., Wu, M., Scott, K. L., Kwong, L. N., Xiao, Y., Cordon‐Cardo, C., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010770 · Cited by 262
Flagged first, then by citations
Research works printed but not linked: 1
- Kobayashi, K., Saheki, T. & Song, Y. Z. Citrin deficiency. GeneReviews http://www.ncbi.nlm.nih.gov/books/NBK1181/ (2005)
Cited by
Sorted by citations
Items 301–382 of 382
Zhao, J., Tian, X., Zhang, J., Huang, C., Sun, Y., Qiao, S., & Jiang, S. (2023) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-023-3706-0 · Cited by 2
Metabolic pathway analysis of tumors using stable isotopes
Bi, Q., Zhao, J., Nie, J. H., & Huang, F. (2025) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2025.05.002 · Cited by 3
The differential regulation of the urea cycle in tumors goes awry
Abou‐Shanab, A. M., Khedr, M. A., & Matosevic, S. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117365 · Cited by 3
Metabolism in the tumor cell and beyond
Carracedo, A. (2023) · Molecular Oncology · doi:10.1002/1878-0261.13467 · Cited by 2
Sukjoi, W., Young, C., Acland, M., Siritutsoontorn, S., Roytrakul, S., Klingler‐Hoffmann, M., Hoffmann, P., & Jitrapakdee, S. (2024) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1250423 · Cited by 2
Single-Cell DNA Sequencing Reveals Chromosomal Diversity in HCC and a Novel Model of HCC Evolution
Wilson, S. R., & Duncan, A. W. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.09.065 · Cited by 2
Patton, M. E., Kelekar, S., Taylor, L. J., Dean, A. E., Zuo, Q., Thakare, R. N., Lee, S. H., Gentry, E. C., Panitchpakdi, M. W., Dorrestein, P. C., et al. (2024) · eLife · doi:10.7554/elife.96783 · Cited by 2
Chang, S. M., Munim, M. B., Trojan, S., Cox, H., Shevzov-Zebrun, A., Abbott, K. L., Chang, R., & Heiden, M. G. V. (2025) · eLife · doi:10.7554/elife.107123 · Cited by 2
Offin, M. D., Fitzgerald, B. G., Zauderer, M. G., & Doroshow, D. B. (2023) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2022.140 · Cited by 1
Tang, W., & Ma, X. (2025) · Cancer Research Communications · doi:10.1158/2767-9764.crc-24-0553 · Cited by 1
Huang, G., Wei, Y., Hou, X., Jia, X., Yu, Y., Xu, L., & Yu, S. (2025) · Journal of Cell Communication and Signaling · doi:10.1002/ccs3.70040 · Cited by 1
Knipper, K., Lyu, S. I., Tzitzili, E., Spielmann, S.-M., Bruns, C. J., Schmidt, T., Popp, F., & Quaas, A. (2025) · Cancers · doi:10.3390/cancers17223624 · Cited by 1
Targeting autophagy and metabolism for ewing sarcoma
Antoshina, K., Aniskin, D., Stempen, M., Schroeder, B., Timashev, P. S., Ulasov, I. V., Chaudhary, A., & Kharwar, R. K. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-11304-6 · Cited by 1
Taya, M., Fishman, D., Kanani, F., Zinger, L., Merenbakh-Lamin, K., Sosner, S. E., Shendge, A. K., Goldberg, A. K., Wolf, U., Winkler, G., et al. (2026) · Oncogene · doi:10.1038/s41388-025-03640-5 · Cited by 1
Spinosyn A derivatives as ASS1 activators and tumor inhibitors
Huang, X.-Y., Liu, X., Xu, N., 彭廷, Hu, X.-Y., Su, M., Zy, L., Liu, S.-Y., & Ma, D. (2026) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2026.130537 · Cited by 1
Zhang, X., Luo, Q., & Zhao, Y. (2026) · Animals · doi:10.3390/ani16071016 · Cited by 1
Dynamic control of nucleotide metabolism in physiology and disease
Kim, D., & Hoxhaj, G. (2026) · Nature Cell Biology · doi:10.1038/s41556-026-02004-9 · Cited by 1
Ariav, Y., Hayek, S., Cantore, T., Sanghvi, N., Adler, L. N., Darzi, N., Pal, L. R., Crawford, D. R., Malleron, T., Silverbeck, J., et al. (2026) · Cancer Research · doi:10.1158/0008-5472.can-26-1818 · Cited by 1
Self-citationArulananda, S., & John, T. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2016.2854 · Cited by 1
Wolkersdorfer, A. M., Bergmann, B., Adelmann, J., Ebbinghaus, M., Günther, E. G., Gutmann, M., Hahn, L., HURWITZ, R. M., Krähmer, R., Leenders, F., et al. (2024) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.4c00473 · Cited by 1
Vo, V. T. A., Tran, L. N., Bùi, T. H., Lee, H., & Jeong, Y. (2025) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-025-00726-6 · Cited by 1
Yu, S., Wang, H., Gao, J., Liu, L., Sun, X., Wang, Z., Wen, P., Shi, X., Shi, J., Guo, W., et al. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.863536 · Cited by 1
Kishimoto, S., Brender, J., Matsumoto, S., Seki, T., Oshima, N., Merkle, H., Reed, G. D., Chen, A. P., Ardenkjær‐Larsen, J. H., Munasinghe, J., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/511543 · Cited by 1
Gartrell, J., Mellado-Largarde, M., Martinez, N. E., Clay, M. R., Bahrami, A., Sahr, N. A., Sykes, A. D., Blankenship, K., Hoffmann, L., Jia, X., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.11.05.370155 · Cited by 1
Chang, S. M., Munim, M. B., Trojan, S., Shevzov-Zebrun, A., Abbott, K. L., & Heiden, M. G. V. (2025) · eLife · doi:10.7554/elife.107123.1 · Cited by 1
Austin, M. J., Patel, S., Kesmez, R. T., Kalampalika, F., Davies, C., Sud, A., Kizilors, A., Lea, N. C., Inocêncio, P., Tappenden, A., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.21.724233 · Cited by 1
Therapeutic Exploitation of Metabolic Checkpoints In Cancer Cells
Patel, D. (2017) · CUNY Academic Works (City University of New York)
Mintser, O. P., & Заліський, В. М. (2018) · Medical Informatics and Engineering · doi:10.11603/mie.1996-1960.2018.3.9464
Ifnar1 signaling breaks the hepatic urea cycle to regulate adaptive immunityPreprint
Lercher, A., Bhattacharya, A., Popa, A., Caldera, M., Schlapansky, M. F., Baazim, H., Májek, P., Brunner, J. S., Kosack, L., Vitko, D., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/762310
Tumor starvation by deprivation of glutamine and aspartate
Fried, R., Carlton, R. M., & Fried, D. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-824013-7.00008-0
Kit, O. I., Kotieva, I. M., Frantsiyants, E. M., Surikova, E. I., Kaplieva, I. V., Bandovkina, V. A., Trepitaki, L. K., Neskubina, I. V., & Pogorelova, Y. A. (2021) · Siberian Journal of Oncology · doi:10.21294/1814-4861-2021-20-3-67-75
Studies on a novel enzyme NAD+ :L- penicillamine ADPtransferase from Bacillus sphaericus
柳谷, 純. (1997) · Okayama University Scientific Achievement Repository (Okayama University) · doi:10.11501/3130735
The roles and mechanisms of urea cycle enzymes in tumor
Wei, M., Rui, Q. I. A. O., Zhang, J., Zhang, X., JiaXin, Y. U., & Li, L. (2022) · Scientia Sinica Vitae · doi:10.1360/ssv-2021-0436
Bazzini, A., & Wu, Q. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.733671641.793549014
Li, G., Xiao, K., Li, Y., Gao, J., He, S., & Li, T. (2022) · Research Square · doi:10.21203/rs.3.rs-2182862/v1
Arginine limitation causes a directed DNA sequence evolution response in colorectal cancer cellsPreprint
Hsu, D. J., Gao, J., Yamaguchi, N., Pinzaru, A. M., Nandan, M. O., Liberti, M. V., Heissel, S., Alwaseem, H., Tavazoie, S., & Tavazoie, S. F. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.02.521806
Badeaux, M. D., Rolig, A. S., Agnello, G., Enzler, D., Kasiewicz, M. J., Priddy, L., Wiggins, J. F., Muir, A., Sullivan, M. R., Cleef, J. V., et al. (2023) · doi:10.1158/2326-6066.c.6550171
Badeaux, M. D., Rolig, A. S., Agnello, G., Enzler, D., Kasiewicz, M. J., Priddy, L., Wiggins, J. F., Muir, A., Sullivan, M. R., Cleef, J. V., et al. (2023) · doi:10.1158/2326-6066.c.6550171.v1
Metabolic Reprogramming of Clear Cell Renal Cell Carcinoma and Its Clinical Significance
周, 文. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.1451486
Rossini, C. V. T., Guimarães, L. M. F., Bento, C. A., Alves-de-Moraes, L. B. C., Jukemura, J., Machado, M. C. C., Reis, E. M. R., & Lameu, C. (2024) · Research Square · doi:10.21203/rs.3.rs-4400868/v1
Gene expression analysis of the L-arginine pathway in renal cell carcinoma
Yu, Y., & Liu, H. (2024) · BIO Web of Conferences · doi:10.1051/bioconf/202411101021
SLC7A5 is required for citrulline-dependent growth in arginine limited conditionsPreprint
Dunlap, K. N., Bender, A., Bowles, A., Bott, A. J., Rutter, J. P., & Ducker, G. S. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.27.600869
Untargeted Metabolite Profiling Reveals Acute Toxicity of Pentosidine on Adipose Tissue of Rats
Hu, C., Shao, Z., Wu, W., & Wang, J. (2024) · Metabolites · doi:10.3390/metabo14100539
Chang, S. M., Munim, M. B., Trojan, S., Cox, H., Shevzov-Zebrun, A., Abbott, K. L., Chang, R., & Heiden, M. G. V. (2026) · eLife · doi:10.1101/2025.05.09.653205
Patton, M. E., Kelekar, S., Taylor, L. J., Dean, A. E., Zuo, Q., Thakare, R. N., Lee, S.-H., Gentry, E. C., Panitchpakdi, M. W., Dorrestein, P. C., et al. (2025) · eLife · doi:10.7554/elife.96783.2
Iyer, S., & Schlichtholz, B. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.168024 · Cited by 1
Kumar, A. A., Iqbal, S., Nestaite, E., Pentinmikko, N., Broberg, M. E., Morikka, J., Hietakangas, V., & Katajisto, P. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.08.28.672976
Govindarajan, M., Waas, M., Meija-Guerrero, S., Lin, B., Ling, T., Li, X., Ignatchenko, V., Tikhonova, A. N., Jones, C. L., Ailles, L., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.02.673726
Patton, M. E., Kelekar, S., Taylor, L. J., Dean, A. E., Zuo, Q., Thakare, R. N., Lee, S.-H., Gentry, E. C., Panitchpakdi, M. W., Dorrestein, P. C., et al. (2025) · eLife · doi:10.7554/elife.96783.3
Rogers, L. C., Zhou, J., Baker, A., Schutt, C. R., Panda, P. K., & Van Tine, B. A. (2021) · Figshare · doi:10.6084/m9.figshare.13627465
Rogers, L. C., Zhou, J., Baker, A., Schutt, C. R., Panda, P. K., & Van Tine, B. A. (2021) · Figshare · doi:10.6084/m9.figshare.13627453
Rogers, L. C., Zhou, J., Baker, A., Schutt, C. R., Panda, P. K., & Van Tine, B. A. (2021) · Figshare · doi:10.6084/m9.figshare.13627462
Rogers, L. C., Zhou, J., Baker, A., Schutt, C. R., Panda, P. K., & Van Tine, B. A. (2021) · Figshare · doi:10.6084/m9.figshare.13627456
Rogers, L. C., Zhou, J., Baker, A., Schutt, C. R., Panda, P. K., & Van Tine, B. A. (2021) · Figshare · doi:10.6084/m9.figshare.13627471
Rogers, L. C., Zhou, J., Baker, A., Schutt, C. R., Panda, P. K., & Van Tine, B. A. (2021) · Figshare · doi:10.6084/m9.figshare.13627468
Rogers, L. C., Zhou, J., Baker, A., Schutt, C. R., Panda, P. K., & Van Tine, B. A. (2021) · Figshare · doi:10.6084/m9.figshare.13627459
Patton, M. E., Kelekar, S., Taylor, L. J., Dean, A. E., Zuo, Q., Thakare, R. N., Lee, S. H., Gentry, E. C., Panitchpakdi, M. W., Dorrestein, P. C., et al. (2025) · eLife · doi:10.7554/elife.96783.4
Huang, M., Wan, X., Wu, J., Chen, H., Sun, C., Zhang, L., & Liu, M. (2026) · European journal of medical research · doi:10.1186/s40001-026-03943-7
Ling, X., Zhao, W., Li, K., Liang, L., Jia, W., Wang, J., Feng, Y., Xu, C., Lv, Q., Feng, Z., et al. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-07779-x
Li, M., Huang, X.-Y., Liu, X.-H., Shao, H., Hu, X.-Y., Su, M., Ni, S., Cao, H.-H., Tian, G., Zhu, X.-Y., et al. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c03466
Cancer immunotherapy with oncolytic myxoma virus
Carmona, J., Nguyen, D., & Rahman, M. (2026) · Advances in cancer research · doi:10.1016/bs.acr.2026.02.002
Chessel, E., Khatir, W., Silva, A. C. B. S., Abbe, P., Béranger, G. E., Ding, Z., Passeron, T., Ben‐Sahra, I., Montaudié, H., Robert, C., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.17.712479
NFATC2-mediated CST1 upregulation drives cholangiocarcinoma growth and metastasis
Zhao, W., Zhao, J., Li, K., Shi, J., Cong, L., & Yu, G. (2026) · Cell Death Discovery · doi:10.1038/s41420-026-03036-8
The anti-tumoral effects of a low protein diet and of the IRE1α signaling
Turtos, A. M. (2022) · theses.fr (ABES) · doi:10.70675/fd90a3e8ze35az42fdzbd0ez966f12ddad22
Li, R., Tang, Y., Ding, Y., Hu, P., Lv, C., Alimu, X., Xiaoyi, W., Wang, X., Hu, M., Zhang, Y., et al. (2026) · Circulation · doi:10.1161/circulationaha.126.079030
Nucleotide Metabolism and DNA Repair: Implications in Cancer Treatments
Priyadarshi, N., Abbas, F. E., Thakur, D., Thakur, S., & Dilawari, R. (2026) · DNA · doi:10.3390/dna6020025
Sun, L., Yu, Y., Li, M., Xu, Z., Cheng, Z., Chen, Y., Li, F., & Zang, C. (2026) · Agriculture · doi:10.3390/agriculture16121314
Fu, Y., Qi, Y., Xing, Y., Lin, Y., Liu, Z., Fu, J., Yao, B., & Zhao, P. (2026) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2026.117919
Targeting amino acid metabolism in hepatocellular carcinoma
Wu, Y., & Wong, C. C.-L. (2026) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2026.06.002 · Cited by 1
Dewi, D. L., Manik, E., Damayanti, E., Anwar, M., Suratno, & Iryanto, S. B. (2026) · Metabolomics · doi:10.1007/s11306-026-02459-9
Zhao, W., Li, S., & Li, W. (2026) · Functional & Integrative Genomics · doi:10.1007/s10142-026-01973-2
Li, M., Zhang, J., Zhang, H., Chen, X., Zou, X., Wang, J., Huang, W., Peng, H., Jia, H., & Hou, Z. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117621
Transsulfuration links aspartate–asparagine metabolism and redox homeo-stasis to drive tumor growthPreprint
Milošević, M., Dmytruk, K., Alghadi, A. Y., Jakoubě, P., Soon, J. W., Hyroššová, P., Munim, M. B., Fernandes, S. I., Shevzov-Zebrun, A., Stanko, R., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.07.10.737826
Wang, H., Sun, P., Li, P., Yang, M., Tong, J., Ma, S., & Zhang, X. (2026) · Fishes · doi:10.3390/fishes11080457
Li, G., He, Z., Liu, M., Zhao, J., Zhu, H., Zhou, C., Wang, Z., He, X., Tang, J., & Jiang, P. (2026) · Nature Metabolism · doi:10.1038/s42255-026-01586-w
Zhang, Y., Gao, Y., Dong, S., Liu, S., Liu, L., Ziyi, S., Xu, J., Rong, Y., Song, G., Zhang, Y., et al. (2026) · Cell Proliferation · doi:10.1111/cpr.70283
Research Progress on Argininosuccinate Synthetase 1 in Tumor Metabolism and Precision Therapy
刘, 佳. (2026) · Advances in Clinical Medicine · doi:10.12677/acm.2026.16103561
Metadata
- Authors
- Rabinovich, S., Adler, L., Yizhak, K., Sarver, A., Silberman, A., Agron, S., Stettner, N., Sun, Q., Brandis, A., Helbling, D., Korman, S., Itzkovitz, S., Dimmock, D., Ulitsky, I., Nagamani, S. C. S., Ruppin, E., & Erez, A.
- Affiliations
- Weizmann Institute of Science (IL)
- Tel Aviv University (IL)
- Baylor College of Medicine (US)
- Medical College of Wisconsin (US)
- Hadassah Medical Center (IL)
- Corresponding author
- Erez, Ayelet
- ORCID
- Venue
- Nature
- Published
- 2015-11
- Volume
- 527
- Issue
- 7578
- Pages
- 379-383
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4655447
- OpenAlex
- W2129920232
- Cited by
- 382
- References
- 26
- Citations by year
- 2026: 31 · 2025: 45 · 2024: 34 · 2023: 38 · 2022: 48 · 2021: 58 · 2020: 30 · 2019: 32 · 2018: 30 · 2017: 19 · 2016: 15 · 2015: 1
- FWCI
- 9.40
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Doris Duke Charitable Foundation (2013095)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (U54HD083092)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Keywords
- argininosuccinate synthetase, aspartate transcarbamylase, dihydroorotase, pyrimidine synthesis, urea cycle, citrullinemia, citrin, aspartic acid, mTOR signaling, S6K1, tumor cell proliferation, metabolic reprogramming, citrulline
- MeSH terms
- Animals, Argininosuccinate Synthase, Aspartate Carbamoyltransferase, Aspartic Acid, Calcium-Binding Proteins, Carbamoyl-Phosphate Synthase (Glutamine-Hydrolyzing), Cytosol, Dihydroorotase, Enzyme Activation, Humans, Male, Neoplasms, Phosphorylation, Pyrimidines, Down-Regulation, Mice, SCID, Citrullinemia, Organic Anion Transporters, Cell Line, Tumor, Cell Proliferation, Mice, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review